GH Research PLC
GHRS
$20.65
$0.301.47%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 19.92% | -11.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.27% | 0.99% | |||
| Operating Income | -12.27% | -0.99% | |||
| Income Before Tax | -34.17% | -0.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -34.17% | -0.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.17% | -0.83% | |||
| EBIT | -12.27% | -0.99% | |||
| EBITDA | -11.85% | -1.42% | |||
| EPS Basic | -34.18% | -0.84% | |||
| Normalized Basic EPS | -29.47% | -0.19% | |||
| EPS Diluted | -34.18% | -0.84% | |||
| Normalized Diluted EPS | -29.47% | -0.19% | |||
| Average Basic Shares Outstanding | -0.01% | 0.02% | |||
| Average Diluted Shares Outstanding | -0.01% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||